SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001078782-20-000357
Filing Date
2020-05-19
Accepted
2020-05-19 16:12:35
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 PRELIMINARY PROPECTUS SUPPLEMENT f424b5051220_424b5.htm 424B5 364262
2 IMAGE f424b5051220424b51.jpg GRAPHIC 247477
3 IMAGE f424b5051220424b52.jpg GRAPHIC 13763
4 IMAGE f424b5051220424b53.jpg GRAPHIC 6409
5 IMAGE f424b5051220424b54.jpg GRAPHIC 6298
6 IMAGE f424b5051220424b55.jpg GRAPHIC 59489
  Complete submission text file 0001078782-20-000357.txt   824674
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-227248 | Film No.: 20893723
SIC: 2835 In Vitro & In Vivo Diagnostic Substances